Turkey Company Roundup: First Biosimilar, Fraud Case Decision
This article was originally published in PharmAsia News
Arven Ilac is to launch Turkey’s first locally produced biosimilar, while a court has acquitted ex-Abdi Ibrahim employees of faud charges. Meanwhile, the Competition Authority has granted initial local approval for Sanofi and Boehringer Ingelheim’s global business swap, and a local hepatitis B vaccine is developed.
Register for our free email digests: